Pancreatic Cancer Research

ResearcherSamsung (South Korea)Active in the last 2 years

Jong Kyun Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-9384-3079; OpenAlex author ID A5101545198. Sources: ClinicalTrials.gov.

Their work

Papers
8 (first author 1, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 trial · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 8

  1. Evaluation of Exosome-derived Small RNAs as Potential Biomarkers for Pancreatic Ductal Adenocarcinoma Using Next-generation Sequencing. Co-author DOI 10.3343/alm.2025.0121↗
  2. Single-cell transcriptome analysis reveals subtype-specific clonal evolution and microenvironmental changes in liver metastasis of pancreatic adenocarcinoma an… Co-author DOI 10.1186/s12943-024-02003-0↗
  3. Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker. Co-author DOI 10.3389/fonc.2020.616440↗
  4. Comparison of 22-gauge standard fine needle versus core biopsy needle for endoscopic ultrasound-guided sampling of suspected pancreatic cancer: a randomized cr… Co-author DOI 10.1080/00365521.2017.1390597↗
  5. The differentiation of autoimmune pancreatitis and pancreatic cancer using imaging findings. First author DOI 10.5754/hge11946↗
  6. Serum CA19-9, cathepsin D, and matrix metalloproteinase-7 as a diagnostic panel for pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/pmic.201200101↗
  7. New-onset diabetes patients need pancreatic cancer screening? Co-author DOI 10.1097/mcg.0b013e318238348c↗
  8. Is health screening beneficial for early detection and prognostic improvement in pancreatic cancer? Last author DOI 10.5009/gnl.2011.5.2.194↗

Trials 1

  1. A Study to Evaluate the Effectiveness and Safety of EUS-guided Transluminal Drainage With 'Niti-S SPAXUS Stent' Principal investigator NCT02730663↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kyu Taek Lee · 7 shared papers, 2011–2025 · strength 0.68
  2. Joo Kyung Park · 3 shared papers, 2020–2025 · strength 0.50
  3. Kwang Hyuck Lee · 4 shared papers, 2012–2025 · strength 0.42
  4. Jin Ho Choi · 2 shared papers, 2024–2025 · strength 0.40
  5. Semin Lee · 2 shared papers, 2024–2025 · strength 0.40
  6. Kee‐Taek Jang · 3 shared papers, 2013–2024 · strength 0.30
  7. Hye Min Kim · 2 shared papers, 2020–2024 · strength 0.28
  8. Hyemin Kim · 1 shared paper, 2025 · strength 0.22
  9. Young Hoon Choi · 1 shared paper, 2025 · strength 0.22
  10. Seung-Ok Lee · 1 shared trial, 2016 · strength 0.11
  11. Se Woo Park · 1 shared trial, 2016 · strength 0.11
  12. Chang Min Cho · 1 shared trial, 2016 · strength 0.11
  13. Jong Ho Moon · 1 shared trial, 2016 · strength 0.11
  14. Sang Soo Lee · 1 shared trial, 2016 · strength 0.11
  15. Byeong Geun Song · 1 shared paper, 2020 · strength 0.10
  16. Hongbeom Kim · 1 shared paper, 2020 · strength 0.10
  17. Yoonhyeong Byun · 1 shared paper, 2020 · strength 0.10
  18. Jin‐Young Jang · 1 shared paper, 2020 · strength 0.10
  19. Wooil Kwon · 1 shared paper, 2020 · strength 0.10
  20. Dong Hyo Noh · 1 shared paper, 2018 · strength 0.08
  21. Juhee Cho · 1 shared paper, 2018 · strength 0.08
  22. Jae Uk Shin · 1 shared paper, 2013 · strength 0.04
  23. Jae Hoon Lim · 1 shared paper, 2013 · strength 0.04
  24. Jin Hee Lee · 1 shared paper, 2012 · strength 0.03
  25. Kwang Won Kim · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.